OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences
Laura C. Coates, Laure Gossec
Joint Bone Spine (2022) Vol. 90, Iss. 1, pp. 105469-105469
Open Access | Times Cited: 25

Showing 25 citing articles:

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 706-719
Open Access | Times Cited: 83

Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis
Philip J. Mease, Soumya M. Reddy, Sarah J. Ross, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003423-e003423
Open Access | Times Cited: 9

Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis
Rucsandra Cristina Dascălu, Andreea Lili Bărbulescu, Loredana Elena Stoica, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 535-535
Open Access | Times Cited: 9

JAK Inhibitors in Psoriatic Disease
Matteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3129-3145
Open Access | Times Cited: 16

Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis
Laure Gossec, Brittany Humphries, Megan J. Rutherford, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5

Recent developments for new investigational JAK inhibitors in psoriatic arthritis
Francesco Caso, Luisa Costa, Paola Triggianese, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 361-371
Closed Access | Times Cited: 12

Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry
Konstantinos D Vassilakis, Charalampos Papagoras, Nikolaos Fytanidis, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2427-2432
Open Access | Times Cited: 4

A review on anterior uveitis and spondyloarthritis with a focus on the interdisciplinary approach between ophthalmologists and rheumatologists
Elena Bolletta, Filippo Crescentini, Pietro Gentile, et al.
Saudi Journal of Ophthalmology (2025) Vol. 39, Iss. 1, pp. 20-30
Closed Access

Refractory psoriatic arthritis: emerging concepts in whole process management
Haili Xu, Ziye Wang, Liling Xu, et al.
Clinical Rheumatology (2025)
Closed Access

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
Camilla Mazzanti, Marino Paroli, G. Santoboni, et al.
Journal of Psoriasis and Psoriatic Arthritis (2025)
Closed Access

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study
Laura C. Coates, Laure Gossec, Miriam Zimmermann, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003977-e003977
Open Access | Times Cited: 3

Glucocorticoids in rheumatology: myths vs. reality
Д. Г. Рекалов, I.Yu. Golovach, И. А. Бринер, et al.
MOJ Orthopedics & Rheumatology (2024) Vol. 16, Iss. 1, pp. 17-23
Open Access | Times Cited: 2

Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52‐Week Results From Two Phase 3 Studies
Iain B. McInnes, Philip J. Mease, Yoshiya Tanaka, et al.
ACR Open Rheumatology (2024) Vol. 6, Iss. 11, pp. 720-731
Open Access | Times Cited: 2

Managing psoriatic arthritis in different clinical scenarios
Rubén Queiró, Marta Loredo, Ignacio Braña, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1469-1484
Closed Access | Times Cited: 4

Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study
Beatriz Joven, Concepción Fito Manteca, Estéban Rubio, et al.
Advances in Therapy (2023) Vol. 40, Iss. 12, pp. 5415-5431
Open Access | Times Cited: 4

An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis
Lily Watson, Conor Coyle, Caroline Whately‐Smith, et al.
Lara D. Veeken (2023)
Open Access | Times Cited: 4

Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries
Sella Aarrestad Provan, Lotta Ljung, Eirik Klami Kristianslund, et al.
The Journal of Rheumatology (2024) Vol. 51, Iss. 11, pp. 1111-1118
Open Access | Times Cited: 1

Liver fibrosis in inflammatory arthritis patients treated with methotrexate and hydroxychloroquine: A FIB‐4 index analysis
G. Sandal Uzun, B. Bulat, Gizem Ayan, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 10
Open Access | Times Cited: 1

Combination of methotrexate with oral disease-modifying antirheumatic drugs in psoriatic arthritis: a systematic review
Tyng‐Shiuan Hsieh, Tsen‐Fang Tsai
Immunotherapy (2023) Vol. 16, Iss. 2, pp. 115-130
Closed Access | Times Cited: 1

Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review
Y.-C. Yeh, Tsen‐Fang Tsai
Dermatology and Therapy (2024) Vol. 14, Iss. 1, pp. 59-81
Open Access

Two sides of management recommendations for psoriatic arthritis
Ennio Lubrano, Fabio Massimo Perrotta
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 7, pp. 397-398
Closed Access

Comparing Treatment Guidelines for Axial Spondyloarthritis
Enrique R. Soriano, Victoria Navarro‐Compán, Wilson Bautista‐Molano, et al.
JCR Journal of Clinical Rheumatology (2024)
Closed Access

Page 1

Scroll to top